BioSpace News Archive

DNases, Ligases, And RNA Polymerases Market Size, Report 2022 to 2030

The global DNases, ligases, and RNA polymerases market size was estimated at USD 611.97 million in 2021 and it is expected to surpass around USD 1.4 billion by 2030, poised to grow at a CAGR of 9.63% from 2022 to 2030.

October 25, 2022
·
8 min read
Immunofluorescence Assay Market Size, Share, Report 2022-2030

According to Vision Research Reports, the global immunofluorescence assay market size is expected to surpass around USD 4.61 billion by 2030, poised to grow at a CAGR of 6.8% from 2022 to 2030.

October 25, 2022
·
7 min read
Meningitis Diagnostic Testing Market Size, Share | Report 2022-2030

Meningitis is the inflammation of the spinal and brain cord membrane caused by bacterial or viral infection. Viral infection is most commonly caused by a virus such as enteroviruses, mumps virus, and herpes simplex virus.

October 25, 2022
·
5 min read
Microcarrier Market Size to Hit Around USD 5.10 Billion by 2030

According to Vision Research Reports, the global microcarrier market size is expected to hit around USD 5.10 billion by 2030 and growing at a CAGR of 11.4% from 2022 to 2030.

October 25, 2022
·
5 min read
Multiplex Assay Market Size to Hit Around USD 3.97 BN by 2030

According to Vision Research Reports, the global multiplex assay market was surpassed at USD 2.06 billion in 2021 and is expected to hit around USD 3.97 billion by 2030, growing at a CAGR of 7.56% from 2022 to 2030.

October 25, 2022
·
13 min read
Nucleic Acid Based Therapeutics Market Size, Growth, Report 2022-2030

According to Latest Study, the global nucleic acids based therapeutics market was valued at USD 536 million in 2021 and it is predicted to surpass around USD 771.52 million by 2030 with a CAGR of 4.13% from 2022 to 2030.

October 25, 2022
·
7 min read
Policy

FDA Roundup: October 25, 2022

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

October 25, 2022
·
3 min read
Business

Nektar to Announce Financial Results for the Third Quarter 2022 on Thursday, November 3, 2022, After Close of U.S.-Based Financial Markets

Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter 2022 on Thursday, November 3, 2022, after the close of U.S.-based financial markets.

October 25, 2022
·
1 min read
Genetown

Fluent BioSciences showcasing breakthrough solutions to enable unprecedented scale, cost-efficiency and access for single-cell RNA sequencing at the 2022 American Society of Human Genetics (ASHG) conference

Fluent BioSciences announced it will be presenting its novel solution for single-cell RNA sequencing through a sponsored presentation and a series of poster sessions at the American Society of Human Genetics (ASHG) conference in Los Angeles between October 25-29, 2022.

October 25, 2022
·
2 min read
Pharm Country

DotLab shares primary market research findings for its novel DotEndo™ test

Today, DotLab is sharing primary, qualitative market research findings regarding receptivity to and interest in the company’s novel endometriosis diagnostics.

October 25, 2022
·
2 min read